ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132791 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132791; 2) Community: the network communities that were significantly associated with the response to NSC 132791; 3) Molecule: the relationships between components within communities and NSC 132791; 4) MDR: the compounds that were significantly associated with the NSC 132791.

NSC Compound Enrichment Correlation
NSC 684459 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 4-(4-bromo- phenyl)-5,6-dihydro-2-phenyl- 0.0208632511155816 -0.26144332
NSC 684836 Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.0208632511155816 0.098392994
NSC 696990 Null 0.0208632511155816 0.095684465
NSC 698959 Null 0.0208632511155816 0.22084843
NSC 718153 Null 0.0208632511155816 0.29275585
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0208632511155816 0.21308012
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0208632511155816 0.33896609
NSC 99733 Rheumygin 0.0208632511155816 0.1670619
NSC 12455 Acid Alizarin Red B 0.0208632511155817 0.29063283
NSC 637603 2H-1,4-Benzothiazin-3-one, 3,4-dihydro-2-[2-[(2,5-dimethylphenyl)amino]-2-oxoethyl]- 0.0210461623330205 -0.13288089
Total:73  Current:32    [First] [Prev] [Next] [Last]